Search
The overarching goal of the Australian coronavirus disease 2019 (COVID-19) vaccination program has been to protect all people in Australia from the harm caused by the novel coronavirus SARS-CoV-2. This review reflects on the role of the Australian Technical Advisory Group on Immunisation (ATAGI) in the national COVID-19 vaccination program, in terms of the initial programmatic and clinical recommendations in the evolving context of evidence relating to the disease and vaccines, epidemiology, and the program rollout.
We aimed to describe the clinical spectrum and burden of COVID-19-associated neurologic disease in Australian children.
Researchers leading a study into COVID-19 vaccine hesitancy say a sub-group of people they’ve dubbed the ‘wait awhiles’
Peter Richmond MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials Group
Desiree Dr Jackie Lisa Susan Silva Davis Gibson Prescott MBBS, FRACP, MPH, PhD BSc (Hons), PGradDipHlthProm, PhD BA (Hons), MPsych, PhD MBBS BMedSci
A number of organisations have created COVID-19 resources specifically developed for Aboriginal and Torres Strait Islander people.
A letter to the WA public from Jonathan Carapetis and Fiona Stanley.
The Kids Research Institute Australia position on schools and COVID-19 in Western Australia
Engaging the community in COVID-19 rapid research
The research that is reducing the impact on families done by The Kids Research Institute Australia.